United States Liquid Biopsy Market to be Dominated by Multi-Gene Parallel Analysis Technology till 2027
High spending on novel diagnostics technology and Increased focus on early cancer screening are driving the demand for United States liquid biopsy Market in the forecast period, 2023-2027. According to TechSci Research report, “United States Liquid Biopsy Market By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free… Read More »